Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,134 JPY | 0.00% | -0.10% | +1.97% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
Evolution of the average Target Price on Takeda Pharmaceutical Company Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Takeda Pharmaceutical Company Limited
Jefferies & Co. | |
TD Cowen | |
BofA Securities | |
Cowen | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- 4502 Stock
- Consensus Takeda Pharmaceutical Company Limited